Methods and kits for discovery of RNA-binding antimicrobials
AssigneeRibotargets, Ltd.
InventorsJonathan Karn, David Justin Charles Knowles, Alastair Iain Hamilton Murchie, Georg Friedrich Lentzen
Life of this patent
Estimating the term…
Loading patent…
AssigneeRibotargets, Ltd.
InventorsJonathan Karn, David Justin Charles Knowles, Alastair Iain Hamilton Murchie, Georg Friedrich Lentzen
Estimating the term…
The invention provides a method for determining whether a test compound binds to a target RNA, the method comprising the steps of: (a) contacting the test compound with a pair of indicator molecules comprising an antimicrobial labelled with a donor group or an acceptor group and the target RNA labelled with a complementary acceptor or donor group, the pair being capable of binding to each other in an orientation that permits the donor group to come into sufficient proximity to the acceptor group to permit fluorescent resonance energy transfer and/or quenching to take place; and (b) measuring the fluorescence of the target RNA and/or the antimicrobial in the presence of the test compound and comparing this value to the fluorescence of a standard.
A method for determining whether a test compound binds to a target RNA, the method comprising the steps of:
A kit for determining whether a test compound binds to a target RNA, the kit comprising (a) a target RNA labelled with a donor group or an acceptor group and (b) an antimicrobial labelled with a group that is acceptor or donor to the label on said target RNA, wherein the antimicrobial and the target RNA bind to each other in an orientation that permits the donor group to come into sufficient proximity to the acceptor group to permit fluorescent resonance energy transfer and/or quenching.
A method for determining the presence in a biological sample of a compound that binds to a target RNA molecule, comprising
Dependencies are inferred from the claim text.